{
    "organizations": [],
    "uuid": "de05cdc48237375d73960167572e8e0aaf067e93",
    "author": "",
    "url": "https://www.reuters.com/article/brief-tesaro-says-anaphylactic-shock-oth/brief-tesaro-says-anaphylactic-shock-other-hypersensitivity-reactions-reported-for-varubi-injectable-emulsion-idUSASB0C0VC",
    "ord_in_thread": 0,
    "title": "BRIEF-Tesaro Says Anaphylactic Shock, Other Hypersensitivity Reactions Reported For Varubi Injectable Emulsion",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 12 (Reuters) - Tesaro Inc:\n* TESARO ANNOUNCES UPDATES TO THE U.S. PRESCRIBING INFORMATION FOR VARUBI (ROLAPITANT) INJECTABLE EMULSION\n* TESARO INC - CHANGES TO LABELING INCLUDE MODIFICATIONS TO CONTRAINDICATIONS, WARNINGS AND PRECAUTIONS, AND ADVERSE REACTIONS SECTIONS\n* TESARO - ANAPHYLAXIS, ANAPHYLACTIC SHOCK HAVE BEEN REPORTED FOR VARUBI INJECTABLE EMULSION POSTMARKETING SETTING, SOME REQUIRING HOSPITALIZATION\n* TESARO - OTHER “SERIOUS” HYPERSENSITIVITY REACTIONS HAVE ALSO BEEN REPORTED FOR VARUBI INJECTABLE EMULSION POSTMARKETING SETTING\n* TESARO - MOST REACTIONS HAVE OCCURRED DURING OR SOON AFTER INFUSION OF VARUBI INJECTABLE EMULSION AND WITHIN FIRST FEW MINUTES OF ADMINISTRATION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-13T00:53:00.000+02:00",
    "crawled": "2018-01-13T01:13:50.011+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "tesaro",
        "inc",
        "tesaro",
        "announces",
        "update",
        "prescribing",
        "information",
        "varubi",
        "rolapitant",
        "injectable",
        "emulsion",
        "tesaro",
        "inc",
        "change",
        "labeling",
        "include",
        "modification",
        "contraindication",
        "warning",
        "precaution",
        "adverse",
        "reaction",
        "section",
        "tesaro",
        "anaphylaxis",
        "anaphylactic",
        "shock",
        "reported",
        "varubi",
        "injectable",
        "emulsion",
        "postmarketing",
        "setting",
        "requiring",
        "hospitalization",
        "tesaro",
        "serious",
        "hypersensitivity",
        "reaction",
        "also",
        "reported",
        "varubi",
        "injectable",
        "emulsion",
        "postmarketing",
        "setting",
        "tesaro",
        "reaction",
        "occurred",
        "soon",
        "infusion",
        "varubi",
        "injectable",
        "emulsion",
        "within",
        "first",
        "minute",
        "administration",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}